2026· International review of neurobiology· Vol 191, pp.
487-507
· 0 citations
Medicine
TL;DR
Various categories of biomarkers, including protein aggregates, inflammation-related factors, oxidative stress markers, metabolomic and lipidomic signatures, genetic and epigenetic status, and PD-related exosomes are discussed, could serve as a diagnostic tool for PD and may provide predictive measures of disease outcomes.
The urgent need for reliable biomarkers, early diagnosis, and multidisciplinary disease-modifying strategies for future therapeutic interventions is highlighted, with particular emphasis on challenges associated with bench-to-bedside translation.
Jeewanjot Singh, Subhi Sharma, Prabhjot Singh et al.· 0 citations
The blood-based biomarkers represent a transformative step toward early diagnosis, large-scale screening, and precision medicine in AD, with significant potential for the development of disease-modifying therapies.
Greata Rubavathi Eliazer, M. Kandasamy· International review of neur...· 0 citations
This paper systematically reviews the experimental evidence supporting the regulatory role of deep brain stimulation at multiple levels, including the correction of abnormal neural discharges, the attenuation of pathological neural oscillations, the modulation of neurotransmitter transmission, the remodelling of synapt...
Yi-Ding Peng· Theoretical and Natural Scie...· 0 citations
Disease-modifying therapies remain investigational, but future directions include biological staging, precision phenotyping, synuclein-targeted immunotherapy, lysosomal enhancement, neuroinflammation modulation, digital biomarkers, and integrated trials across the Lewy body disease spectrum.
A. Abyad· World Family Medicine Journa...· 0 citations
Neurofilament (NF) proteins, as integral components of the neuronal cytoskeleton, are essential for maintaining axonal structure and function. Genetic defects, aberrant post-translational modifications, and co-aggregation with other pathogenic proteins can disrupt NF homeostasis, leading to axonal injury and neuronal d...
Xiao-Wen Zhao, Yi-Ying Hu· Ageing and Neurodegenerative...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.